BALAXI PHARMACEUTICALS cash flow

·UnclassifiedChart ›
Latest FY26
Cash from operations
−₹4.5cr−₹35.0 cr in FY25
Capital spending
₹14.9cr+995.2% on FY25
Free cash flow
−₹19.4cr−₹36.4 cr in FY25
Cash from financing
₹0.4cr−98.7% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—2.21.92.11.8
—3.92.90.00.5
—0.02.60.05.8
—15.90.00.00.0
Changes in working capital
—−5.03.722.9−6.3
—−25.3−55.1−3.4−24.8
—0.60.00.00.0
—0.0−1.2−0.30.1
—−5.9−2.4−4.8−0.7
—2.70.00.00.0
—0.00.00.0−0.0
—5.0−12.9−5.50.0
—0.00.00.0−15.8
—0.80.01.80.0
—0.0−0.00.00.8
Cash from operating activities
6.55.328.72.056.9
—−5.1−60.512.8−38.8
—0.2−31.814.818.2
—0.00.0−1.70.0
—0.00.0−4.90.0
—4.73.26.712.1
—−4.5−35.04.96.1
Cash from investing activities
—14.91.40.710.8
—5.90.60.91.9
—0.019.8−0.52.3
—0.00.00.04.5
—0.00.00.0−0.1
—−20.8−21.8−1.0−10.6
Cash from financing activities
—0.00.025.818.5
—0.02.70.00.0
—4.234.06.08.0
—−0.10.00.00.0
—0.10.10.00.1
———0.10.0
—3.72.81.50.4
—0.00.00.00.5
—0.00.10.00.0
—0.433.930.325.5
—−24.8−22.934.121.0
—0.062.30.00.0
—−24.839.434.121.0
———62.328.2
Reference items
9.08.537.246.756.5
3.2%3.2%12.7%19.4%16.8%
−19.4−19.4−36.44.2−4.7
—−18.9−5.28.7—
−₹3.51−₹3.51−₹6.59₹0.76−₹0.86
—−3.18×−1.40×−2.04×0.13×
—4.73.26.712.1
—3.72.81.50.4
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BALAXI₹19.71

BALAXI PHARMACEUTICALS LIMITED

· Unclassified
₹ CrorePeersPARSTEELCITYLATTEYSCROWNHECPROJECTHINDCONAIROLAMGROBTEAMcap ₹109 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation1.82.11.92.2—
+ Finance Costs0.50.02.93.9—
+ Unrealised FX (Gain) / Loss5.80.02.60.0—
+ Other Non-cash Items0.00.00.015.9—
Changes in Working Capital
+ Inventories-6.322.93.7-5.0—
+ Trade Receivables — Current-24.8-3.4-55.1-25.3—
+ Trade Receivables — Non-current0.00.00.00.6—
+ Other Financial Assets — Current0.1-0.3-1.20.0—
+ Other Current Assets-0.7-4.8-2.4-5.9—
+ Other Non-current Assets0.00.00.02.7—
+ Other Bank Balances-0.00.00.00.0—
+ Trade Payables — Current0.0-5.5-12.95.0—
+ Trade Payables — Non-current-15.80.00.00.0—
+ Other Financial Liabilities — Current0.01.80.00.8—
+ Other Current Liabilities0.80.0-0.00.0—
Cash from Operating Activities
Profit Before Tax (per I/S)56.92.028.75.36.5
+ Total Adjustments (incl. Working Capital)-38.812.8-60.5-5.1—
Cash from Operations (pre-tax)18.214.8-31.80.2—
+ Interest Paid — Operating0.0-1.70.00.0—
+ Other Inflows / (Outflows) — Operating0.0-4.90.00.0—
+ Income Taxes Paid12.16.73.24.7—
Cash from Operating Activities6.14.9-35.0-4.5—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)10.80.71.414.9—
+ Acq of Goodwill1.90.90.65.9—
+ Acq of Other Long-term Assets2.3-0.519.80.0—
+ Disp of Other Long-term Assets4.50.00.00.0—
+ Other Inflows / (Outflows) — Investing-0.10.00.00.0—
Cash from Investing Activities-10.6-1.0-21.8-20.8—
Cash from Financing Activities
+ Proceeds from Issue of Shares18.525.80.00.0—
+ Proceeds from Exercise of Stock Options0.00.02.70.0—
+ Proceeds from Borrowings8.06.034.04.2—
+ Repayment of Borrowings0.00.00.0-0.1—
+ Payment of Lease Liabilities0.10.00.10.1—
+ Payment of Finance Lease Liabilities0.00.1———
+ Interest Paid0.41.52.83.7—
+ Dividends Paid0.50.00.00.0—
+ Other Inflows / (Outflows) — Financing0.00.00.10.0—
Cash from Financing Activities25.530.333.90.4—
Net Changes in Cash (pre-FX)21.034.1-22.9-24.8—
+ Effect of FX Rate Changes on Cash0.00.062.30.0—
Net Changes in Cash21.034.139.4-24.8—
Closing Cash28.262.3———
Reference Items
EBITDA56.546.737.28.59.0
EBITDA Margin %16.8119.3712.723.163.23
Free Cash Flow (CFO − Capex)-4.74.2-36.4-19.4-19.4
Free Cash Flow to Equity—8.7-5.2-18.9—
Free Cash Flow per Basic Share-0.860.76-6.59-3.51-3.51
Cash Flow to Net Income0.13-2.04-1.40-3.18—
Cash Paid for Taxes12.16.73.24.7—
Cash Paid for Interest0.41.52.83.7—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.